Vanguard Global Advisers
RXST icon

Vanguard Global Advisers’s RxSight RXST Stock Holding History

Vanguard Global Advisers’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.6K Hold
15,278
– – ﹤0.01% 2927
2026
Q1 		$94.1K Buy
+15,278
New +$127K ﹤0.01% 2752

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 37.48% 1-Year Est. Return

Vanguard Global Advisers's RXST Position: Q2 2026 in Review

Vanguard Global Advisers held its RxSight (RXST) position steady in Q2 2026 at 15,278 shares worth $73.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2927.

Vanguard Global Advisers first reported a position in RXST in Q1 2026 and has held it in 2 quarters since. The position peaked at $94.1K in Q1 2026. 147 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Vanguard Global Advisers held 15,278 shares of RxSight worth $73.6K as of Q2 2026.
  • Vanguard Global Advisers left its RxSight share count unchanged in Q2 2026.
  • RxSight made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2927 holding.
  • Vanguard Global Advisers first reported a position in RxSight in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's RxSight position peaked at $94.1K in Q1 2026.
  • 147 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.